If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Laura Farina is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Leukoencephalopathy With Predominant Infratentorial Involvement Caused by a Novel ABCD1 Mutation: Does the Spinocerebellar Variant of Adrenoleukodystrophy Exist?

Benzoni, C., Farina, L., Pensato, V., Marotta, G., Kuqo, A., Mauro, E., Pareyson, D. & Salsano, E., Nov 1 2019, In : The neurologist. 24, 6, p. 194-197 4 p.

Research output: Contribution to journalArticle

  • Microwave thermal ablation using CT-scanner for predicting the variation of ablated region over time: advantages and limitations

    Strigari, L., Minosse, S., D'Alessio, D., Farina, L., Cavagnaro, M., Cassano, B., Pinto, R., Vallati, G. & Lopresto, V., Apr 17 2019, In : Physics in Medicine and Biology.

    Research output: Contribution to journalArticle

  • Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

    Cuneo, A., Follows, G., Rigolin, G. M., Piciocchi, A., Tedeschi, A., Trentin, L., Perez, A. M., Coscia, M., Laurenti, L., Musuraca, G., Farina, L., Delgado, A. R., Orlandi, E. M., Galieni, P., Mauro, F. R., Visco, C., Amendola, A., Billio, A., Marasca, R., Chiarenza, A. & 24 others, Meneghini, V., Ilariucci, F., Marchetti, M., Molica, S., Re, F., Gaidano, G., Gonzalez, M., Forconi, F., Ciolli, S., Cortelezzi, A., Montillo, M., Smolej, L., Schuh, A., Eyre, T. A., Kennedy, B., Bowles, K. M., Vignetti, M., De La Serna, J., Moreno, C., Foà, R., Ghia, P., Party, GIMEMA., (ERIC), E. R. I. O. CLL. & forum, UK. CLL., 2018, In : Haematologica. 103, 7, p. 1209-1217 9 p.

    Research output: Contribution to journalArticle

    Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

    Cuneo, A., Follows, G., Rigolin, G. M., Piciocchi, A., Tedeschi, A., Trentin, L., Perez, A. M., Coscia, M., Laurenti, L., Musuraca, G., Farina, L., Delgado, A. R., Orlandi, E. M., Galieni, P., Mauro, F. R., Visco, C., Amendola, A., Billio, A., Marasca, R., Chiarenza, A. & 24 others, Meneghini, V., Ilariucci, F., Marchetti, M., Molica, S., Re, F., Gaidano, G., Gonzalez, M., Forconi, F., Ciolli, S., Cortelezzi, A., Montillo, M., Smolej, L., Schuh, A., Eyre, T. A., Kennedy, B., Bowles, K. M., Vignetti, M., De La Serna, J., Moreno, C., Foà, R., Ghia, P., Party, GIMEMA., (ERIC), E. R. I. O. CLL. & forum, UK. CLL., 2018, In : Haematologica. 103, 7, p. 1209-1217 9 p.

    Research output: Contribution to journalArticle

    KARS-related diseases: Progressive leukoencephalopathy with brainstem and spinal cord calcifications as new phenotype and a review of literature

    Ardissone, A., Tonduti, D., Legati, A., Lamantea, E., Barone, R., Dorboz, I., Boespflug-Tanguy, O., Nebbia, G., Maggioni, M., Garavaglia, B., Moroni, I., Farina, L., Pichiecchio, A., Orcesi, S., Chiapparini, L. & Ghezzi, D., Apr 4 2018, In : Orphanet Journal of Rare Diseases. 13, 1, 45.

    Research output: Contribution to journalArticle